Moderna Inc.’s stock erased early losses to gain 3.4% on Friday, after the biotech company posted a wider-than-expected ...

Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Moderna shares fell after the biotech company swung to a quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion, or $2.91 per share, ...

Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...

Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.

COVID-19 has impacted nearly every aspect of life. Although tens of thousands of cases continue to occur each week, the world ...

The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...

A man believed to be in his 30s is in critical condition following a shooting early Friday morning near 3rd Avenue and Pike Street, Seattle police said. (KOMO) TOPICS: SEATTLE — A man believed ...

In a report released today, Tyler Van Buren from TD Cowen maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $35.00. Tyler Van Buren’s rating is based on a ...

How Long Does COVID Last? You may wonder if COVID-19 is still a thing or how long an infection lasts, especially if you're having symptoms. For most people with mild infections, COVID goes away ...

Retired U.S. Army bomb disposal expert Rep. Brian Mast praised President Donald Trump's plan to reinstate service members booted for refusing the COVID-19 vaccine with the brush of a pen ...